These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28483148)

  • 1. Treatment of locally advanced parotid malignancies with parotidectomy and temporal bone resection.
    Martin JR; Filip P; Thorpe EJ; Leonetti JP
    Am J Otolaryngol; 2017; 38(4):380-382. PubMed ID: 28483148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased local recurrence in advanced parotid malignancy treated with mastoidectomy without lateral temporal bone resection.
    Kadakia S; Chan D; Ducic Y; Cristobal R; Mourad M
    Oral Maxillofac Surg; 2017 Mar; 21(1):7-11. PubMed ID: 27696236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral temporal bone and parotid malignancy with facial nerve involvement.
    Mantravadi AV; Marzo SJ; Leonetti JP; Fargo KN; Carter MS
    Otolaryngol Head Neck Surg; 2011 Mar; 144(3):395-401. PubMed ID: 21493202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Parotid Malignancies—10 Years of Experience.
    Kopeć T; Mikaszewski B; Jackowska J; Waśniewska-Okupniak E; Szyfter W; Wierzbicka M
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1397-402. PubMed ID: 25850920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary and non-primary parotid malignancies: comparison of treatment modalities and outcomes.
    Morinière S; Périé S; Lacau St Guily J
    Eur Arch Otorhinolaryngol; 2007 Oct; 264(10):1231-7. PubMed ID: 17534637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parotid salivary duct carcinoma: a single institution's 20-year experience.
    Stodulski D; Mikaszewski B; Majewska H; Kuczkowski J
    Eur Arch Otorhinolaryngol; 2019 Jul; 276(7):2031-2038. PubMed ID: 31062093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult Temporal Bone Facial Nerve Involvement by Parotid Malignancies with Perineural Spread.
    Carlson ML; Patel NS; Modest MC; Moore EJ; Janus JR; Olsen KD
    Otolaryngol Head Neck Surg; 2015 Sep; 153(3):385-91. PubMed ID: 26129739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors and Outcomes Associated With Temporal Bone Resection for Primary Parotid Malignancy.
    Tanavde VA; Broderick J; Windon MJ; Fakhry C; Stewart CM; Eisele DW; Creighton FX
    Laryngoscope; 2021 Aug; 131(8):E2461-E2468. PubMed ID: 33797071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parotid tumors: a 10-year experience.
    Lin CC; Tsai MH; Huang CC; Hua CH; Tseng HC; Huang ST
    Am J Otolaryngol; 2008; 29(2):94-100. PubMed ID: 18314019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent pleomorphic adenoma of the parotid gland.
    Leonetti JP; Marzo SJ; Petruzzelli GJ; Herr B
    Otolaryngol Head Neck Surg; 2005 Sep; 133(3):319-22. PubMed ID: 16143173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The results of temporal bone surgery for advanced or recurrent tumors of the parotid gland.
    Gidley PW; Thompson CR; Roberts DB; Weber RS
    Laryngoscope; 2011 Aug; 121(8):1702-7. PubMed ID: 21792957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence Based Tailored Parotidectomy in Treating External Auditory Canal Carcinoma.
    Lee JM; Joo JW; Kim SH; Choi JY; Moon IS
    Sci Rep; 2018 Aug; 8(1):12112. PubMed ID: 30108249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative parotidectomy for the treatment of parotid cancers.
    Lim YC; Lee SY; Kim K; Lee JS; Koo BS; Shin HA; Choi EC
    Oral Oncol; 2005 Nov; 41(10):1021-7. PubMed ID: 16129655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.
    Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parotid metastatic disease from cutaneous squamous cell carcinoma: prognostic role of facial nerve sacrifice, lateral temporal bone resection, immune status and P-stage.
    Shao A; Wong DK; McIvor NP; Mylnarek AM; Chaplin JM; Izzard ME; Patel RS; Morton RP
    Head Neck; 2014 Apr; 36(4):545-50. PubMed ID: 23780509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtotal temporal bone resection en bloc with the parotid gland and temporomandibular joint: a 2-dimensional operative video.
    Komune N; Kuga D; Hashimoto K; Fujiwara Y; Shimamoto R; Nakagawa T
    Am J Otolaryngol; 2021; 42(4):103081. PubMed ID: 34052059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parotidectomy: a review of 112 patients treated at a teaching hospital in Pakistan.
    Ali NS; Nawaz A; Rajput S; Ikram M
    Asian Pac J Cancer Prev; 2010; 11(4):1111-3. PubMed ID: 21133633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of adenoid cystic carcinoma in the parotid gland.
    Casler JD; Conley JJ
    Otolaryngol Head Neck Surg; 1992 Apr; 106(4):332-8. PubMed ID: 1314372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elective parotidectomy in the management of advanced auricular malignancies.
    Osborne RF; Shaw T; Zandifar H; Kraus D
    Laryngoscope; 2008 Dec; 118(12):2139-45. PubMed ID: 19029866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of the margin in parotid surgery for pleomorphic adenoma.
    Witt RL
    Laryngoscope; 2002 Dec; 112(12):2141-54. PubMed ID: 12461331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.